Marie-Ange Noue is a PhD chemist trained at Curie University in Paris and at the University of Houston. She started her career working as a research scientist in petrochemicals. She later found her niche upon joining EMD Serono in 2008, where she’s held a number of positions of increasing responsibility. In her current role as Senior Director, Head of US Scientific Communications, she provides strategic leadership and oversight for activities related to Medical Information, Medical Communication, Medical Training, and Medical Education for the US. Marie-Ange chairs the Board of Directors of the Canadian Medical information network, and serves as Vice President on the Executive Board of PhactMI.

Elizabeth Brown is an Executive Director in Medical Writing & Disclosure at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years, as a laboratory scientist, a clinical researcher, a medical writer and an organizational leader. With her project and people management focus, she has developed a passion for developing people, advising teams, and providing strategic guidance how to create efficient, effective, and high-quality scientific communication deliverables.

Elizabeth C. Froom, PharmD, is a Senior Director in the Medical Writing and Healthcare Communications team at PPD. She has over 20 years of medical information and writing experience. In her role she provides strategic direction and oversight to a global team of medical writers who deliver medical information services including standard response documents, custom responses, Academy of Managed Care Pharmacy (AMCP) dossiers, infographics, and promotional review. Her educational background includes a BS in pharmacy and a PharmD from the University of South Carolina College of Pharmacy.

Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.

As ever-questioning medical communication professional with an international reputation, I have been communicating science to children, grandmothers, business professionals, government agencies, and scientific experts for more than 15 years. My technical areas of expertise span across infectious disease, immunology, oncology, and vaccines and include content deliverables at all stages within a product's lifecycle.

Yvonne joined Gilead Sciences, Inc in 2011 and currently the Director, Strategic Capabilities lead for Global Medical Information. In this role, she drives strategic planning, business performance, and resource management while ensuring alignment across key stakeholders. She leads a global team to enhance operational excellence, support business innovation and oversee inspection and audit readiness.

Elizabeth Olbrich, RN, MS, is known for engaging teams through hands-on leadership and conviction to do what it takes to produce quality output and achieve milestones. She has earned reputation for fostering positive vendor/client relationships, establishing and leading teams, and vendor performance turn-around. Elizabeth has provided strategic leadership for global medical writing, CRO partnerships, and quality control activities. She currently oversees a global medical information program involving 12 medical writers and editors who deliver over 1,000 annual documents while exceeding client KPIs.

Dr. Nimita Limaye leads R&D Strategy and Technology at IDC Health Insights, providing research-based advisory and consulting services on the Life Sciences industry. She represents Healthcare and life science on IDC's AI Council. She is an executive business leader with more than two decades of life sciences leadership experience in the pharma/CRO/tech consulting industry. She focuses on the role of data and technology in transforming drug development, RWD, synthetic data and analyzing and predicting evolving trends in the life sciences industry. Nimita was the chair of the SCDM board, chaired several conferences roundtables, given keynote talks, participated in fireside chats, and authored close to a 100 thought leadership papers.

While working on her PhD, Sudipta discovered her passion for helping the public better understand science. In her first position as a medical writer, Sudipta learned of the new requirements for patient-friendly summaries of clinical trial results. Since then, Sudipta has worked with over 20 sponsors in developing a pipeline of plain language deliverables. She has also built teams that effectively use health literacy and patient-focused strategies in their communications. Currently, Sudipta is a Senior Manager of Clinical Trial Transparency at Biogen, where she oversees transparency commitments and leads initiatives to help Biogen become more patient-centered in their communications.

Fabiana Ebihara has over 19 years of extensive experience in the field of medical writing, with a particular focus on leadership and regulatory medical writing. Throughout her career, Fabiana has held several key leadership positions at Parexel International, where she has played a pivotal role in managing medical writing partnerships with pharmaceutical companies. She provided financial and operational oversight and led projects covering a range of therapeutic areas. Fabiana has successfully collaborated with her clients, implemented process improvements, and mentored cross-regional teams.

Richard Swank is the former head of US Field Medical and Global Field Medical Excellence at Amgen and Founder of Scientific Engagement LLC. He has spent most of his career building medical capabilities in Medical Affairs, including building and managing MSL teams, managing medical information call centers, and improving how medical teams execute and measure field medical performance. He holds a PhD in Biochemistry and Molecular Biology and prior to joining industry completed an NIH Postdoctoral Fellowship and was a senior fellow in Medical Genetics at the University of Washington.

Iris Tam, PharmD, FAMCP, is Senior Vice President & Head of Medical Affairs and HEOR at COEUS Consulting with 34 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair.

Sarah Jarvis leads our Global Medical & Evidence consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for over 25 years and has focused exclusively on working with medical affairs clients for the past 15 years at ZS. ZS has worked with more than 100 companies' Medical Affairs organizations. Sarah also previously worked at Genentech in a variety of different roles on products that spanned therapy areas and phases of the lifecycle. With COVID acting as an accelerator on the medical function, ZS is partnering with clients to support the growth and change needed to meet global demands - in the field and in headquarters - through strategy, advanced analytics, and operations projects.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

In Craig’s more than 30 years working at Lilly, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig is a founding member of the Medical Science Liaison (MSL) program at Lilly where he worked in the New York City Metropolitan area for over 13 years in this field role. Craig spent 6 years as the MSL Trainer for Lilly USA and in 2017 became part of the Office of Medical Professional Development where is he assumed the role of the Global MSL trainer. Craig has been very active in developing benchmarking survey data on MSL standards across the pharmaceutical industry. Craig received the DIA Excellence in Service award in 2021. Craig retired from Lilly in 2024.

Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 20 years in the biopharma industry. Currently at Argenx, his experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, digital, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.

Maria Paula offers expert scientific content guidance and project management support for DIA's global consortium initiatives and specialty meetings. She is dedicated to ensuring the development and delivery of impactful, patient-centric scientific content that generates evidence to facilitate the integration of innovation in medical product development. She brings experience in public health, patient engagement, and research management. She holds a Master of Science in Health Care Management from Marymount University and a Bachelor of Science in Microbiology and Bioanalysis from Universidad Industrial de Santander, Colombia.

In her current role, she provides strategic leadership and oversight for activities related to Medical Information and Medical Information Digital solutions. She began her career as a community pharmacist, before joining the Pharmaceutical Advertising Advisory Board (PAAB) as an Assistant Commissioner. She joined Lilly, 25 years ago, first supporting Medical Information before holding various roles in Legal, Sales, Compliance and Medical Affairs. Joanna obtained her B.Sc. in pharmacy from the University of Toronto and her MBA from the Schulich School of Business. Joanna is also a board member of the Pharmacovigilance and Medical Information Network (PVN-MI) Canada.

Tamei Elliott, MS, serves as the Associate Director of Scientific Programs for the Americas region at DIA. In this pivotal role, she is responsible for identifying and prioritizing content areas and topics crucial to DIA constituents. Tamei assesses the implications of significant regulatory and health policy changes, seamlessly integrating relevant content into the development and advancement of DIA conferences and courses. Her responsibilities extend to overseeing content development and strategy within the Americas region.

John Jones is an experienced IT Strategist focused on developing innovative technology solutions for unmet business needs in Life Sciences. John is currently the Founder and CEO of Entitech Solutions, a Life Sciences focused IT Software and Consulting firm. Prior to starting his company, John led Quintiles’ IT Consulting Division from 2010 – 2015 focusing on IT Advisory and Implementation services in Life Sciences. John has more than 20 years experience in developing and delivering IT Solutions for various companies, and has extensive experience in the clinical, regulatory, and commercial areas.

Rob is a Director of Medical Information at Johnson & Johnson responsible for the overall leadership of the Heme Oncology Medical Information team. His team has a focus on developing responses to medical information requests from HCPs and the provision of medical review for scientific and promotional materials. In addition to his 17 years of pharmaceutical industry experience, Rob also has 11 years of experience as a practicing pharmacist in various pharmacy settings. Rob earned his Bachelor of Science in Pharmacy from Temple University, his Doctor of Pharmacy degree from Shenandoah University, and his MBA from Drexel University.

Kari is Vice President and Chief Compliance Officer for Cytokinetics, Inc., where she provides executive management, direction, and oversight for all aspects of the compliance program, policies, monitoring, training, privacy, and brand-legal advisory. Previously, Kari was the US Healthcare Compliance and Privacy Officer and Senior Corporate Counsel at Vifor Pharma, Inc., and a Senior Director/Senior Compliance Counsel at Jazz Pharmaceuticals. She has extensive experience in providing legal and compliance advice on sales, marketing, promotional and medical materials review, Medical Affairs, managed care, commercial compliance, as well as U.S. Sunshine / aggregate spend and compliance operations.

Meet Sajida Roberson, a dynamic consultant blending strategic leadership with hands-on expertise to drive impactful business transformations. With a proven track record in global pharmaceutical companies, Sajida seamlessly transitioned from corporate strategy roles to independent consulting, delivering both visionary solutions and actionable results. Sajida excels in solving complex challenges, streamlining operations, and achieving sustainable outcomes. She brings a broad range of experience in financial optimization, organizational change, and project management, ensuring practical and impactful solutions for her clients. Sajida’s approach leverages Agile principles and Lean Six Sigma practices to transition organizations to adaptiv

Dave brings over 14 years of Medical Information Contact Center Management and Operations experience. A licensed Registered Nurse, he began his career as a front-line Medical Information Specialist and has continually advanced into roles of increasing responsibility within the Medical Affairs industry. He is currently the Senior Director, Medical Information Service Delivery (Operations and Account Management) at ProPharma. Dave's passion for the patient and HCP experience is evident in his approach to staff selection, employee development and operational excellence of his teams.

Patricia Bourne, PharmD, Senior Director, Medical Sciences at Cytokinetics has over 25 years of industry experience leading both therapeutic and managed care field teams. At Cytokinetics, Patricia is responsible for leading the development of medical strategies that support market access and driving field tactics with a goal of patient access and improving patient outcomes. She has owned a retail pharmacy, worked as a clinical pharmacist and Director of Pharmacy Services at a managed care organization giving additional perspectives in healthcare. Before joining Cytokinetics, she led the Medical Affairs' market access strategies at Gilead Sciences across a range of therapeutic areas and population-based decision maker teams.

Rico Calara is a scientist by training with a PhD in Medical Sciences from the Karolinska Institute in Stockholm, Sweden. With 25 years of experience, he has held positions in Target Discovery, Clinical Development, and Medical Affairs. Rico is focused on developing advanced analytics and insights frameworks aimed at enhancing the integration of clinical evidence into practice. He collaborates cross-functionally with teams in Pre-Clinical to Medical Affairs, utilizing AI tools to uncover meaningful insights from complex datasets. His work is instrumental in informing and refining strategic initiatives while simplifying the communication of the value and impact of functional activities to uncover meaningful insights from complex datasets.

Lisa Chamberlain James is a Senior Partner and Chief Executive Officer of Trilogy Writing & Consulting. Aside from management activities, she also leads client projects, with extensive experience in a variety of documents and a special interest in drug safety and patient information. After receiving her Ph.D. in Pathology, Lisa began her medical writing career in Cambridge in 2000. Since then, she has been heavily involved in the EMWA on the Education Committee and as a workshop leader, is a visiting lecturer for King’s College London, initiated and chaired the EMWA PV and Communicating with the Public SIGs, is chair of the Geoff Hall Scholarship Committee, section editor for Medical Writing, and a Fellow of the Royal Society of Medicine.

Michael is the Executive Vice President of Global Medical Affairs and Medical Information at EVERSANA and has 20+ years of healthcare and pharmaceutical industry experience in multiple leadership roles at several pharmaceutical companies. He has extensive experience in medical information, medical communications and in supporting medical review of promotional / non-promotional materials. Throughout his career, Michael has supported multiple product launches, and he has led MI activities from both a US and global perspective. He has led and grown established MI teams and has built a MI department and services from the ground up. His educational background includes Doctor of Pharmacy, MBA, and Master of Science in Regulatory Affairs degrees.

As the Director of Leadership Excellence, Purvi builds leadership capability within medical and commercial teams at EMD Serono, a critical investment in enhancing current and future leaders’ skills, abilities and confidence. Purvi brings 20+ years’ experience, most recently 7 years as a Senior Executive Consultant at the FDA, helping the agency develop their leadership development strategy and approach. As an ICF-certified coach, Purvi has worked with leaders at all levels, helping them gain important insights and empowering them to operationalize who they want to be as leaders. Purvi holds a BS in Health Science from the Univ. of Texas HSC, a MEd in Public Health Ed from Univ. of Houston, and a MPA from George Mason Univ.

Prior to starting Eldridge Writing and Consulting in 2023, Meagan served in medical writing positions of increasing responsibility across both the contract and sponsor sides of the industry. Meagan finds her greatest career joys in ongoing partnerships with collaborative teams to produce high-quality clinical and regulatory documents. In addition to writing for any phase of drug development, her growing company is focused on agile medical writing leadership to optimize the document development process, help clients reach their submission goals, and ultimately bring life-changing therapies to patients.

After receiving her PhD in Developmental Neurobiology, Julia became a medical writer in 1997. In 2002, she co-founded Trilogy Writing & Consulting, a company specialized in medical writing of regulatory documentation. She has twice been President of the European Medical Writers Association (EMWA), is an experienced trainer of medical writers, and runs workshops for EMWA, AMWA, DIA, and pharma companies around the world.

Joanna Gonsalves has 18+years of experience in the bio-pharmaceutical industry. Joanna joined Amgen in April 2010. During her tenure at Amgen Joanna has held a variety of different medical roles in different therapeutic areas. She currently serves as the Head of Field Medical Excellence, where she partners with global field medical teams to empower them with tools, competencies, and culture to be best-in-class today and tomorrow.

Ritama Gupta Dempsey is an Associate Director of Disclosure Medical Writing at Merck & Co., Inc. As the operational head for clinical trial disclosures, she is dedicated to establishing long-term strategies within the evolving transparency landscape. Ritama is passionate about developing talent and building cross-functional relationships with diverse stakeholders to enhance disclosure initiatives. She has a background in academic scientific research and holds a PhD in Immunology and Microbial Pathogenesis from Weill Cornell Graduate School of Medical Sciences.

Jones is an Associate Partner at ZS Associates, a Global Healthcare Management Consulting Firm and leads the Medical Omnichannel / Digital Transformation Domain. He has over a decade of experience and worked with 20+ pharma organizations across omnichannel / digital domains spanning strategy, technology and analytics. He has supported organizations in areas like digital and omnichannel strategy & roadmapping, technology ecosystems, digital blueprint and activation, engagement process redesign, omnichannel orchestration, digital analytics and reporting Jones holds an MBA from Washington University in St. Louis and a Bachelors Degree in Electronics and Communication Engineering from Cochin University, India

Ana Magalhaes is a Senior Manager of Medical Writing at Precision for Medicine with over a decade of clinical trial experience, specializing in documentation and regulatory compliance. Leveraging an academic foundation in clinical research, health sciences, and statistics, Ana optimizes clinical trial processes through the development of regulatory documentation, ensuring consistency and efficiencies from study initiation to completion. Ana has a proven track record in translating complex scientific data into clear and concise protocols that are tailored to address the unique challenges of oncology and rare indications, meet regulatory requirements, and facilitate successful study execution.

Gary Messplay is a Partner in the Washington, D.C., office of King & Spalding. He represents life sciences clients before the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA), and other federal and state agencies. Mr. Messplay's practice includes regulatory and administrative law matters, clinical trials, criminal and civil enforcement matters, healthcare compliance, internal investigations, litigation, liability counseling, and transactional work related to pharmaceutical products. He has written extensively about pharmaceutical compliance issues and is a frequent speaker on regulatory and compliance matters. He is a member of the Food and Drug Law Institute, where he serves on FDLI’s Editorial Advisory Board.

Meera serves as the Head of Global Medical Information, Content at Bayer in Whippany, NJ, where she leads a large, global team responsible for medical information, content strategy and communication, of Bayer's complete pharmaceutical portfolio. Her leadership has driven innovation, including the creation of a dedicated group within Bayer Oncology focused on cutting-edge content and medical insights. Building on over 20 years of pharmaceutical experience, including roles at Johnson & Johnson and Schering-Plough, Meera has participated as a speaker at industry conferences such as DIA Annual and MASC.

Vladimir Penkrat is AVP of Regulatory Affairs at Indegene. With an MBA in International Business, Vladimir has provided strategic leadership throughout his career across clinical development, biometrics, biostatistics, medical writing, pharmacovigilance, and regulatory affairs. Over the past three decades Vlad worked across top pharma, biotech startups, CROs, and consulting firms. Within the recent 10 yrs, Vlad's passion for regulatory excellence has established process leadership in Regulatory Writing, Submissions Management, Publishing, Labelling, CTT, Consulting, & GenAI innovation as a business. Vlad's leadership has enabled businesses to prepare for digital adeptness & as a business leader he has scaled R&D operations to >500 FTE.

Carolyn Quon, PharmD is the Vice President of Global Medical Information Strategic Operations & Digital Solutions at EVERSANA. With over two decades of experience in medical information call centers, project management, and client onboarding, she specializes in delivering effective, efficient solutions and exceptional support to pharmaceutical clients. Her expertise includes global medical information strategies, regulatory compliance, medical information systems, performance metrics, customer service, quality programs, and call center development. Carolyn earned her PharmD from USC and completed a specialized residency in drug information at Stanford University. She also holds a bachelor's degree in biochemistry from UC San Diego.

Jenny has over 19 years of experience in providing global, multilingual Medical Information and Pharmacovigilance contact center services; holding various roles within Operations, Client Services, Management, and Leadership. Much of her career has focused on designing and delivering Medical Information teams across Europe, MEA, the Asia-Pacific region, and the Americas. Working directly with clients to enable, expand, and evolve services and strategies and was involved with integrating several Pharmacovigilance (PV) acquisitions in Europe and supported the globalization of PV functionality. Jenny obtained her Bachelor of Science (BSc) in Biological Sciences from Bristol University and has lived and worked globally throughout her career.

Dr. Jessica Steier is a public health scientist and health services researcher with expertise in health policy evaluation. She is the CEO of Vital Statistics Consulting, a data science consultancy, and founder and host of Unbiased Science, a science communication brand. She is also the executive director of The Science Literacy Lab, a non-profit organization aimed at improving health and science literacy and empowering people to make informed decisions that impact their well-being. Dr. Steier received her Master of Public Health (Evaluative Sciences) at SUNY-Stony Brook University and her Doctor of Public Health degree from the Graduate Center at the City University of New York (CUNY).

Dr. Robin Winter-Sperry is currently the Field Medical Excellence, International / Oncology Lead at Pfizer. With roles of increasing responsibility, she was the Global MSL Lead at Ipsen. Prior to joining Ipsen, she was Head, Global Field Based Medical Excellence and Insights at Sanofi Genzyme after joining as VP, Strategy, MS. With extensive consulting experience as President of Scientific Advantage, she’s been instrumental in Medical Affairs strategy, operations including mergers, transitions and organizational design. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry, responsible for creating and developing many of the industry’s leading Medical Affairs and Field Medical teams.

With 18+ years of experience, Pooja holds a Master's degree in pharmaceutical chemistry and a postgraduate diploma in health communications. She currently leads Medical Communications at Krystelis, managing publications, medico-marketing, and medical education. Pooja specializes in strategic communication for pharma and biotechnology, having worked on public health campaigns, advisory boards, RWEs, and developing consensus statements and clinical guidelines. She has worked with top pharma clients, and other healthcare stakeholders. Pooja is also a published author, having received the PRS Global Open "Best International Collaboration-Gold Award" in 2020. Actively involved as a faculty member in workshops and conferences.

Dr. Crowley-Nowick, is a respected expert in the pharmaceutical industry, bringing nearly 15 years of experience in medical affairs and clinical research. In 2008, Dr. Crowley-Nowick founded Zipher Medical Affairs, Co., LLC., a leading provider of medical affairs strategic consulting & MSL services. She has successfully led late stage biotech & pharma companies through multiple product launches across several therapeutic areas, such as oncology, cardiovascular, and diabetes. Dr. Crowley-Nowick’s patient-centric view & drive for improved patient care & outcomes have propelled her to shape the organization based on not only scientific integrity but also continual collaboration with emerging medical stakeholders.

Lee Ding, PharmD, is Senior Director of Field Health Economic Outcomes Research at BeiGene, with over 25 years of managed care experience across health plans, health systems, and the biopharmaceutical industry. He engages with payers, PBMs, and integrated delivery systems to communicate scientific, health economic, and real-world data, aiming to optimize patient access and outcomes. Previously, he spent 18 years at Genentech/Roche, contributing to 10+ NME launches in multiple therapeutic areas. His experience also includes roles at a Blue Cross Blue Shield plan and an integrated delivery system-owned health plan.

Kim Edwards is the Senior Director of Health Communication Services at the Center for Information and Study on Clinical Research Participation (CISCRP). CISCRP is a non-profit organization focused on increasing awareness and understanding of clinical research participation. Kim oversees the creation of easy-to-understand trial resources for patients, participants, and the public. Kim earned her BS in Neuroscience from Trinity College and PhD in Developmental and Brain Sciences from University of Massachusetts Boston.

Vanessa is the Executive Director and Head of Global Medical Excellence at Gilead Sciences. Vanessa has been active in the industry for over 21 years, elevating teams across Medical Affairs, Marketing and Sales functions.

Dr. Tim Mitchell is Managing Director of Medical Communications & Innovation at Klick. With a PhD in pharmacology and an honors degree in psychology, he previously conducted and published industry-sponsored research at King’s College London before co-founding a global medical communications agency, later acquired. His leadership experience spans Chief Medical Officer roles and oversight of technology, UX, analytics, and engagement strategy teams. Since joining Klick in 2021, he has led the development of high-tech, high-science solutions that transform medical engagement, partnering with global and US medical affairs teams to advance their omnichannel and digital engagement strategies.

Dr. Oladayo Oyelola is Senior Director and Head, Clinical Trial Information Disclosure at Daiichi Sankyo. He oversees corporate clinical trial transparency/data sharing strategies and compliance activities; coordinates internal disclosure operations’ training, process improvements and trial transparency policy intelligence. He holds a PhD in Clinical Chemistry from Obafemi Awolowo Univ. Ile-Ife, Nigeria, 1990 and received The Rockefeller Foundation Postdoctoral Fellowship, 1991 and National Mentor Role Model Award of Minority Access Inc/Office of Minority Health, NIH, 2001. Dr. Oyelola has over 35 years’ experience in biomedical R&D, and certifications by National Registry of Certified Chemists and American Society for Clinical Pathologist

Courtney Phillips, PharmD, is an Associate Director on the Medical Communications Operations team at PPD, part of Thermo Fisher Scientific. With over 6 years at the company, she has extensive experience managing small, medium and large medical information contact center programs. In her role, Courtney offers strategic direction and oversight to an operations management team, ensuring that client deliverables and expectations are consistently met. Courtney received her PharmD from Campbell University College of Pharmacy & Health Sciences.

Maureen Piotrowski is a Senior Medical Writer and Consultant with Whitsell Innovations. She has over 20 years of biotech and pharmaceutical experience, including clinical trial management, orphan drug development, and regulatory writing. In the 10 years she has been with Whitsell Innovations, Maureen has worked with many bio and pharma clients on regulatory documents, from short term projects to years long collaborations.

After earning her PhD in Immunology and working at an immunotherapy start-up, Rebecca started her medical writing career in 2006. Since then, she has contributed to drug or biologic clinical development programs through a number of medical writing positions across contract research and sponsor organizations. Rebecca particularly enjoys strategic writing, efficacy, submission management, and the collaborative nature of the work. She partners with project teams to produce clear, high-quality regulatory documents with consistent messaging. With over 18 years of experience, Rebecca recently started Pogue Writing Solutions LLC in 2025.

Mary is the Global Content Strategy and US Regional Lead for Pfizer Medical Information [MI]. Mary earned both a Bachelors and Doctorate degree in Pharmacy. Mary has greater than 20 years pharmaceutical industry experience specific to medical information. Outside of Pfizer, Mary is active in advancing the medical information profession through her leadership/collaboration roles in the Drug Information Association and phactMI [Pharma Collaboration for Transparent Medical Information]. Mary is currently serving on the phactMI board of directors for the term 2019-2020.

John Shea is an Associate Director of North America Medical Information at EMD Serono, focusing on Oncology products and pipeline. He received his MD/PhD from the Medical University of South Carolina, where his research focus was the role of sphingolipids in signaling in the intersection of pathogens and the immune system. After a residency in Emergency Medicine in Pittsburg, PA, John gravitated towards Medical Communication with particular interests in improving patient health literacy and improving quality and impactful communications among patients, caregivers, and healthcare providers. He’s written several nonfiction books on science, heath, and history for grade schoolers and teenagers.

With 15+ years in disease pathogenesis and scientific research, Preeti Sule leads scientific communication initiatives to make science clear, engaging, and accessible. She specializes in translating complex data into impactful strategies, ensuring innovative therapies reach the right audiences. Passionate about science for all, she believes it should inform, inspire, and empower. Outside work, Preeti enjoys painting and cooking—and once attempted a three-tier cake that became an abstract masterpiece!

Aaron is a seasoned leader in strategy development, program management, and operational excellence. He leads strategic planning and medical excellence for Medical in the U.S. and Canada. He and his team drive key initiatives such as a Generative AI platform for medical insights and impact measurement and a Strategic Territory Planning framework for MSLs. With leadership experience at Biogen and Genzyme, he has led high-impact initiatives, from quality system remediation under FDA consent decree to co-developing three-year medical success horizon strategies. Aaron holds an MBA from Northeastern University and a dual B.S. in Chemical Engineering and Science, Technology & Society from Rensselaer Polytechnic Institute.

I have 18 years experience in healthcare data and analytics, working to generate intelligence across providers, payers and pharma, always with the goal of driving better health outcomes. In my current role at Sorcero, I help Med Affairs teams around the world utilize AI to optimize engagement and drive better care for patients. At GSK, I was Director of Data Science, US Med Affairs. While there, I built a Center of Excellence for Data Science to develop and apply ML and NLP capabilities to accelerate the very manual process of mining unstructured data for insights on customers and patients. As Head of Product at Stratifyd, my remit is to grow our text analytics platform to meet market needs, with a key focus on Medical Affairs.

Stephanie Vezina is Director of Medical Information at Pfizer, where she currently leads the Inflammation and Immunology Category and is the Gen AI Content Lead. With over 25 years of experience in pharmacy practice and the pharmaceutical industry, Stephanie has gained extensive experience leading teams capable of delivering high-quality, compliant, and customer-focused medical information services. In her current role, she also contributes to the implementation of global Medical Information strategies. As the Gen AI content lead, she focuses on advancing GenAI content transformation and overseeing the development of AI capabilities dedicated to optimize efficiency within her organization.

Samantha Winders is a Regulatory Medical Writer at Aroga Biosciences, dedicated to advancing symptom management and enhancing scientific communication. She holds a PhD in Nursing Science from the University of Florida and completed a postdoctoral fellowship at the University of Washington. During her fellowship, her research focused on self-management strategies for individuals with Inflammatory Bowel Disease (IBD), with an emphasis on factors affecting sleep and overall well-being in this population.

> 10 years experience of writing in the pharmaceutical industry. Before joining PAREXEL Medical Writing Services in Jan 2003 he was the Deputy Executive Editor for IMS Health’s R&D Focus. James completed a PhD in apoptosis, and then did a Post-Doc in the role of apoptosis in endometriosis.

Sylvia Baedorf Kassis, MPH has over 25 years of clinical research experience. She currently serves as Program Director at the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard. Her main foci over the past seven years has been on health literacy, return of results, and patient engagement. Her clinical research interests include integrating study participant experiences into research, supporting research coordinators through networks and training, and ensuring researchers have access to vital information that supports the ethical and compliant research conduct. Sylvia earned her MPH in Global Health at Boston University School of Public Health (2008) and a BSc at the University of Toronto (2001).

Michelle is currently the Global Head of Medical Information at Recordati Rare Diseases. She is an advanced practice nurse, toxicologist, and earned her Executive MBA in 2022 and has worked in industry for nearly 20 years in roles including: Medical Device Sales, Med Info, Pharmacovigilance and Medical Affairs. Her most recent areas of interest include increasing the uptake of AI in Med Affairs and in social media strategy for health communication. Michelle is very passionate about Med Info & Med Affairs and is highly motivated by innovative, customer centric ways to support healthcare and non-healthcare professionals around the world to ensure the safe and effective use of medicines.

Erica is a seasoned leader in medical communications with over 15 years of experience partnering with global medical affairs clients. As the Director for Medical Communications Writing at IQVIA, she spearheads the integration of GenAI across her team of medical writers and strategists, driving advancements in compliance, quality, and efficiency. Erica has a passion for publications, and as well as carrying a CMPP accreditation, she is a member of the ISMPP Publication Practices steering committee. Her combined expertise and innovative approach position her as a pivotal figure in revolutionizing medical communications through cutting-edge technologies.

Ann joined Roche in 2008 and became the Field Director of the Ophthalmology Medical Science Liaisons in 2020. Her first leadership role was in 2017 as Associate Director of the Surgical Devices Liaison Team after the Roche acquisition of Forsight Vision4. The team expanded from 5 to 12 and completed Phase II and III trials for the Port Delivery System with ranibizumab, Genentech’s first surgically implanted device. Ann established the team's infrastructure, including Onboarding and training, case support documentation, and KPIs. Before this, she served as an MSL for the CV/Metabolism and Ophthalmology teams and worked in Medical Communications at Janssen and as an MSL at Bristol-Myers Squibb.

Krista is the Director of Clinical Writing & QC at Alcon in Fort Worth, TX. She leads a global team of medical writers and QC specialists supporting Alcon's clinical trials and submissions for devices and pharmaceuticals. With over 25 years of industry experience and a background in statistics, Krista transitioned to medical writing 10 years ago. She played a key role in moving Alcon from a fully outsourced model to a mixed model for medical writing and QC services. Krista is excited to lead this team into the future with quality and excellence, creating lean processes and utilizing breakthrough technologies to deliver high-quality, regulatory-compliant documents that effectively communicate complex data in a clear and concise manner.

Donna Holder has over 30+ yrs experience in the pharma. She is the Executive Director & Head of Digital Strategy and Innovation in Global Oncology Medical Affairs at Daiichi Sankyo where she focuses on implementing digital technology, platform and processes. Previous to that she led Global MSL Excellence at Daiichi Sankyo, Merck & Co, and AstraZeneca. In these roles she drove consistency, standards and the development of tools & processes in Field Medical. Donna has spent the majority of her career in Medical Affairs leading teams across multiple functions. Donna is a PharmD graduate of the University of Michigan.

Dr. Howard is currently the Global Medical Digital Lead in the Medical Operations and Effectiveness group in Sanofi Specialty Care. In this capacity, he is responsible for leading a team to evaluate and develop novel digital platforms and processes to support a fully realized Medical Omnichannel strategy. Specifically, these projects have internal impact, such as NLP insight analysis and social media monitoring, or external impact to facilitate HCP access to the right content, on the right channel, at the right time. Every project is informed by his prior experience in the field as an Oncology MSL with a keen focus on improving field efficiency and maximizing HCP value.

Tim brings more than 18 years of success in corporate strategy, project management, and market research. At Syneos Health, he drives the strategy for customers on how they can utilize data, analytics, and technology to operate more efficiently. Tim spearheads innovation initiatives at Syneos Health to provide cutting edge technology solutions to our customers. He has an excellent history of applying marketing methodologies and data analytics to shape operational strategies and reduce customer costs.

Nga has over 13 years of industry experience ranging from large to medium to small pharma. She had her start in publication writing, and has since then expanded to medical communications and medical information. Her training and background is in public health and prior to joining industry, she was involved in community health in Boston and also spent some time at the WHO in Geneva. She has been involved with the development and commercialization of several vaccines over the course of her industry career and is embracing the challenges in this current environment where vaccines and public health intersections are more important than ever.

Jeanette Towles, MA, RAC, is the CEO of Synterex, Inc., a woman-owned, disability-owned clinical and regulatory consulting firm specializing in agile-based project management methodology, automation, and AI-driven technologies. Prior to that, she held in-house consulting and FTE medical writing and clinical science positions at both small- and large-size companies, including managing a group of programmers and vendors working on automated documents, with cumulative industry experience of nearly 20 years. She lives in the Boston area with her husband, 2 children, and dog.

Lauren Tulloch is Vice President & Managing Director at CCC. In that role, she is responsible for the Corporate Business Unit which includes copyright licenses, the RightFind product suite, and managed knowledge services. Prior, Tulloch held several product management leadership roles in the organization. Before joining CCC, she served as a group publisher at a healthcare education & training company. Tulloch began her career as a newspaper reporter and editor. She holds Bachelor’s degrees in journalism and political science from Boston University.

Simon Johns has over 25 years of experience supporting global pharmaceutical customer projects. As Director of Medical Information (MI) and Marketed Product Safety at IQVIA, he manages global MI projects focused on process optimization and technology enablement to drive enhanced efficiency and customer engagement. Simon is a member of the European DIA Medical Information and Communications Training Team, advising pharmaceutical companies on best industry practices, innovation and automation. He speaks regularly on topics ranging from combined human and AI conversational agent models for MI to the benefits and increased value of integrating MI and pharmacovigilance.

As a seasoned technology entrepreneur and business builder, Woo oversees Xogene’s strategic direction as well as the services and technology divisions. Prior to Xogene, Woo co-founded Intrasphere, a technology and services provider to the biopharmaceutical industry, which was acquired by Deloitte Consulting. Woo also co-founded PharmaCM, a leading clinical disclosure platform, now acquired by Citeline. A former derivatives trader, Woo is also a founder of Reval, a global leader of SaaS platform for treasury and risk management with clients and employees in North America, EMEA, and the Asia Pacific, now a part of Ion Group.

Jenny is the Senior Director, Channel Integration and Innovation Lead for the Global Scientific Communications Team at GSK. She drives omnichannel engagement, generative AI advancements, and analytics to transform scientific communications. Previously, Jenny led the Generative AI Content and Innovation Team at Pfizer, pioneering AI-driven content development. Her work resulted in peer-reviewed publications, international presentations, and innovative AI tools. She also developed digital content strategies and health literacy initiatives. Jenny holds an MS in Biology and Immunology and an MBA in Innovation and Leadership. She serves on the ISMPP Board of Trustees and the MAPS Digital Focus Area Working Group.